Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
AMEERA-3: Randomized Phase II Study of Amcenestrant (Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Monotherapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 22, 2023
Triple negative breast cancer: any closer to cracking the code?
Journal: Current opinion in obstetrics & gynecology
Published: December 30, 2021
Impact of a Palliative Care Nurse Practitioner in an Oncology Clinic: A Quality Improvement Effort.
Journal: JCO oncology practice
Published: November 08, 2021
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 14, 2021
Frontiers in HER2-positive breast cancer in 2020.
Journal: Current opinion in obstetrics & gynecology
Published: December 28, 2020
Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus.
Journal: Therapeutic advances in medical oncology
Published: April 24, 2020
Hormone receptor positive breast cancer: state of the art.
Journal: Current opinion in obstetrics & gynecology
Published: December 19, 2017
Management of Breast Sarcoma.
Journal: The Surgical clinics of North America
Published: August 21, 2016
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential.
Journal: Therapeutic advances in medical oncology
Published: October 25, 2014
Central nervous system toxicities of chemotherapeutic agents.
Journal: Expert review of anticancer therapy
Published: April 22, 2014
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.
Journal: Journal of neuro-oncology
Published: September 05, 2013
Nab-paclitaxel monotherapy in refractory pancreatic adenocarcinoma.
Journal: Journal of gastrointestinal oncology
Published: May 01, 2013
Last Updated: 09/26/2026